Skip to main content

TableĀ 1 Demographics and baseline characteristics

From: Addition of vancomycin to cefazolin is often unnecessary for preoperative antibiotic prophylaxis during total joint arthroplasties

Variable

Vancomycin & Cefazolin (nā€‰=ā€‰1,437)

Cefazolin (nā€‰=ā€‰1,470)

P-value

n

%

n

%

Age (years)

62

Ā 

62

Ā Ā 

BMI (kg/m2)

ā€ƒBMIā€‰<ā€‰20

16

1.1%

32

2.2%

0.020

ā€ƒ20ā€‰<ā€‰BMIā€‰<ā€‰30

543

37.8%

461

31.4%

ā€‰<ā€‰0.001

ā€ƒ30ā€‰<ā€‰BMIā€‰<ā€‰40

546

40.0%

570

38.8%

0.508

ā€ƒBMIā€‰>ā€‰40

170

11.8%

180

12.2%

0.740

Gender

ā€ƒFemale

809

56%

801

54%

0.279

ā€ƒMale

628

44%

669

46%

0.279

Race

ā€ƒAmerican Indian or Alaska Native

4

0.3%

7

0.5%

0.394

ā€ƒAsian

6

0.4%

27

1.8%

ā€‰<ā€‰0.001

ā€ƒBlack or African American

695

48.4%

637

43.3%

0.006

ā€ƒWhite

554

38.6%

745

50.7%

ā€‰<ā€‰0.001

ā€ƒPacific Islander

1

0.1%

1

0.1%

0.999

ā€ƒUnknown

8

0.6%

22

1.5%

0.018

ā€ƒMultiple

31

2.2%

31

2.1%

0.853

Joint

ā€ƒHip

719

50.0%

732

49.8%

0.914

ā€ƒKnee

718

50.0%

738

50.2%

0.914

Alcohol Abuse

451

31.4%

860

58.5%

ā€‰<ā€‰0.001

Tobacco Users

665

46.3%

714

48.6%

0.215

Substance Abuse

91

6.3%

94

6.4%

0.912

Diabetes mellitus

347

24.1%

298

20.3%

0.014

COPD

30

2.1%

34

2.3%

0.713

CHF

48

3.3%

59

4.0%

0.315

HTN

676

47.0%

603

41.0%

0.001

CKD

77

5.4%

51

3.5%

0.013

ASA Class

ā€ƒ1

36

2.5%

37

2.5%

0.999

ā€ƒ2

814

56.6%

875

59.5%

0.113

ā€ƒ3

577

40.2%

547

37.2%

0.097

ā€ƒ4

10

0.7%

8

0.5%

0.485

  1. BMI body mass index, COPD chronic obstructive pulmonary disease, HTN hypertension, CKD chronic kidney disease, ASA American Society of Anesthesiology, CHF congestive heart failure